KNIGHT, Andrea, Pavel NĚMEC, Soňa BRETZOVÁ, Lucie VÁLKOVÁ, Markéta KOLMANOVÁ, Renáta VYTOPILOVÁ, Marek HAVELKA, Pavla VSIANSKA, Lucie RIHOVA, Marta KREJČÍ and Martin PISKÁČEK. Do human B-lymphocytes avoid aging until 60 years? Oncotarget. New York: Impact Journals, 2016, vol. 7, No 28, p. 42873-42880. ISSN 1949-2553. Available from: https://dx.doi.org/10.18632/oncotarget.10146.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Do human B-lymphocytes avoid aging until 60 years?
Authors KNIGHT, Andrea (203 Czech Republic, belonging to the institution), Pavel NĚMEC (203 Czech Republic, belonging to the institution), Soňa BRETZOVÁ (203 Czech Republic, belonging to the institution), Lucie VÁLKOVÁ (203 Czech Republic, belonging to the institution), Markéta KOLMANOVÁ (203 Czech Republic, belonging to the institution), Renáta VYTOPILOVÁ (203 Czech Republic, belonging to the institution), Marek HAVELKA (203 Czech Republic, belonging to the institution), Pavla VSIANSKA (203 Czech Republic), Lucie RIHOVA (203 Czech Republic), Marta KREJČÍ (203 Czech Republic) and Martin PISKÁČEK (40 Austria, guarantor, belonging to the institution).
Edition Oncotarget, New York, Impact Journals, 2016, 1949-2553.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30200 3.2 Clinical medicine
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 5.168
RIV identification code RIV/00216224:14110/16:00088869
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.18632/oncotarget.10146
UT WoS 000385395700003
Keywords in English Aging; B cell; GEP; Gerotarget; IL7R; Naive B cells
Tags EL OK
Tags International impact, Reviewed
Changed by Changed by: Soňa Böhmová, učo 232884. Changed: 10/11/2016 14:14.
Abstract
Broad changes in human innate and adaptive immunity are associated with advanced age. The age-related alteration of gene expression was reported for both T and B lymphocytes. We analysed the genome-wide expression profiles (n=20) of naive and whole B cell populations from young and early aged healthy donors under 60 years. We revealed large homogeneity of all analysed genome-wide expression profiles but did not identified any significant gene deregulation between young (30-45 years) and early aged healthy donors (50-60 years). We argue that B cells avoid the aging program on molecular level until 60 years of age. Our results demonstrate the potential of hematopoietic stem cells to generate uncompromised lymphocytes in early elderly. These are very encouraging findings for the general health and the immunity maintenance would not need any intervention to naive B cells. Rather, a suitable immune stimulation in healthy body environment warrants further research into aging of older elderly.
Links
MUNI/11/InGA09/2013, interní kód MUName: Molekulární charakterizace gamma a delta řetězců T-buněčných receptorů a identifikace ligandů na expandovaných efektorových gamma-delta T-lymfocytech
Investor: Masaryk University
NT14310, research and development projectName: Buněčné stárnutí u hematoonkologických onemocnění
Investor: Ministry of Health of the CR
NV15-32935A, research and development projectName: Analýza gamma-delta T lymfocytů reaktivních na nádorové buňky u pacientů s B-buněčnou chronickou lymfocytární leukémií: nový přístup k buněčné terapii
3SGA5924, interní kód MUName: Investigations of human gamma-delta T cells: a new candidate for novel antiviral and antitumour immunotherapy (Acronym: Gammadelta T cells)
Investor: South-Moravian Region, Incoming grants
PrintDisplayed: 27/7/2024 23:43